SpaceX Falls Back to $135; Raymond James Sees Moonshot
SpaceX is hovering around its $135 IPO price as investors digest post-debut dynamics. One broker, Raymond James, argu...
Timing matters: choose or avoid depending on goals, fees, and flexibility. This guide offers practical criteria to decide for retirement planning.
21,768 articlesSpaceX is hovering around its $135 IPO price as investors digest post-debut dynamics. One broker, Raymond James, argu...
UBS cuts Mosaic’s price target to $27, citing squeezed phosphate margins from higher sulfur and input costs, as Wall ...
Markets are sizing Coca-Cola for a two-year path as AI-driven capital shifts reshape sectors. A fresh price predictio...
Meta Platforms is pursuing a bold path toward a $9 trillion market cap by 2031. This article breaks down the feasibil...
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Oppenheimer boosts its Palo Alto Networks price target to $275 citing strong demand for the Idira identity security p...
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Synopsys posted solid quarterly results but faces Design IP headwinds. The path to a 2027 price target hinges on marg...
Kinross Gold posted a solid Q4 print after the bell, beating expectations with $0.67 in adjusted EPS and outlining 20...
A respected analyst has earmarked Dutch Bros as the best restaurant stock pick, citing traffic gains, digital momentu...
Wednesday brought a wave of fresh analyst calls spanning tech, industrials, and defense as traders weigh earnings and...
U.S. stocks drift as a slate of fresh analyst calls prompts traders to reassess positions in consumer, tech and indus...